Growth Metrics

Ionis Pharmaceuticals (IONS) Shares Issued (2016 - 2025)

Historic Shares Issued for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $81.3 million.

  • Ionis Pharmaceuticals' Shares Issued fell 8338.6% to $81.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.8 million, marking a year-over-year decrease of 8474.75%. This contributed to the annual value of $489.1 million for FY2024, which is 88928.04% up from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Shares Issued stood at $81.3 million for Q3 2025, which was down 8338.6% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Shares Issued registered a high of $489.1 million during Q3 2024, and its lowest value of -$48000.0 during Q2 2021.
  • Moreover, its 5-year median value for Shares Issued was $2.6 million (2023), whereas its average is $39.0 million.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Shares Issued tumbled by 10054.54% in 2021, and later skyrocketed by 1301260.05% in 2024.
  • Ionis Pharmaceuticals' Shares Issued (Quarter) stood at -$48000.0 in 2021, then skyrocketed by 814.58% to $343000.0 in 2022, then soared by 11783.97% to $40.8 million in 2023, then plummeted by 99.93% to $27000.0 in 2024, then surged by 300859.26% to $81.3 million in 2025.
  • Its last three reported values are $81.3 million in Q3 2025, $1.3 million for Q2 2025, and $2.2 million during Q1 2025.